Abstract |
|
Authors | Kentaro Yamazaki, Takayuki Yoshino, Narikazu Boku |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 34
Issue 8
Pg. 1183-91
(Aug 2007)
ISSN: 0385-0684 [Print] Japan |
PMID | 17687199
(Publication Type: Journal Article, Review)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Organoplatinum Compounds
- Vascular Endothelial Growth Factor A
- Oxaliplatin
- Bevacizumab
- Irinotecan
- Leucovorin
- Fluorouracil
- Camptothecin
|
Topics |
- Angiogenesis Inhibitors
(administration & dosage)
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Bevacizumab
- Breast Neoplasms
(drug therapy)
- Camptothecin
(administration & dosage, analogs & derivatives)
- Carcinoma, Non-Small-Cell Lung
(drug therapy)
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Colonic Neoplasms
(drug therapy, metabolism, surgery)
- Drug Administration Schedule
- Drug Approval
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Irinotecan
- Leucovorin
(administration & dosage)
- Lung Neoplasms
(drug therapy)
- Male
- Organoplatinum Compounds
(administration & dosage)
- Oxaliplatin
- Rectal Neoplasms
(drug therapy, metabolism, surgery)
- Vascular Endothelial Growth Factor A
(biosynthesis)
|